Cargando…

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach

BACKGROUND: Lung cancer has the highest mortality of all cancers. The aim of this study was to examine DNA hypermethylation in sputum and validate its diagnostic accuracy for lung cancer. METHODS: DNA hypermethylation of RASSF1A, APC, cytoglobin, 3OST2, PRDM14, FAM19A4 and PHACTR3 was analysed in sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hubers, A J, Heideman, D A M, Burgers, S A, Herder, G J M, Sterk, P J, Rhodius, R J, Smit, H J, Krouwels, F, Welling, A, Witte, B I, Duin, S, Koning, R, Comans, E F I, Steenbergen, R D M, Postmus, P E, Meijer, G A, Snijders, P J F, Smit, E F, Thunnissen, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366885/ https://www.ncbi.nlm.nih.gov/pubmed/25719833 http://dx.doi.org/10.1038/bjc.2014.636

Ejemplares similares

A Fast, Sensitive and Accurate High Resolution Melting (HRM) Technology-Based Assay to Screen for Common K-ras Mutations
por: Kramer, D., et al.
Publicado: (2009)

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment
por: Kuiper, J L, et al.
Publicado: (2016)

A Panel of High Resolution Melting (HRM) Technology-Based Assays with Direct Sequencing Possibility for Effective Mutation Screening of EGFR and K-ras Genes
por: Heideman, D. A. M., et al.
Publicado: (2009)

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
por: Buffart, T E, et al.
Publicado: (2008)

Molecular sputum analysis for the diagnosis of lung cancer
por: Hubers, A J, et al.
Publicado: (2013)

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.
por: Smit, E. F., et al.
Publicado: (1992)

Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease)
por: Phernambucq, E C J, et al.
Publicado: (2006)

Benefit of a second opinion: From metastatic disease to resectable lung cancer with sarcoid-like reaction
por: Schook, Romane M., et al.
Publicado: (2014)

Can quantifying free-circulating DNA in plasma be used to identify subjects with high-grade pre-invasive endobronchial lesions?
por: VAN BOERDONK, ROBERT A.A., et al.
Publicado: (2013)

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.
por: Bakker, M., et al.
Publicado: (1995)

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.
por: Smit, E. F., et al.
Publicado: (1998)

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment
por: Wachters, F M, et al.
Publicado: (2005)

Acute and cumulative effects of carboplatin on renal function.
por: Sleijfer, D. T., et al.
Publicado: (1989)

Bilateral Renal Tumour as Indicator for Birt-Hogg-Dubé Syndrome
por: Johannesma, P. C., et al.
Publicado: (2014)

Hypermethylation of ribosomal DNA in human breast carcinoma
por: Yan, P S, et al.
Publicado: (2000)

Detection of hypermethylated genes as markers for cervical screening in women living with HIV
por: Kremer, Wieke W, et al.
Publicado: (2018)

Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix
por: Giannoudis, A, et al.
Publicado: (2001)

Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy
por: Huisman, C, et al.
Publicado: (2001)

Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis
por: Bacour, Y. A. A., et al.
Publicado: (2023)

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression
por: van der Wekken, A. J., et al.
Publicado: (2017)

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer
por: De Faveri, L E, et al.
Publicado: (2013)

Under-vaccinated groups in Europe and their beliefs, attitudes and reasons for non-vaccination; two systematic reviews
por: Fournet, N., et al.
Publicado: (2018)

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis
por: Henken, F E, et al.
Publicado: (2007)

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
por: Ruiz, M I Galleges, et al.
Publicado: (2009)

Pemetrexed Induced Thymidylate Synthase Inhibition in Non-Small Cell Lung Cancer Patients: A Pilot Study with 3′-Deoxy-3′-[(18)F]fluorothymidine Positron Emission Tomography
por: Frings, Virginie, et al.
Publicado: (2013)

Results of Two Years Expenience with Fluorescence Bronchoscopy in Detection of Preinvasive Bronchial Neoplasia
por: Venmans, Ben J. W., et al.
Publicado: (1999)

LDLR gene’s promoter region hypermethylation in patients with familial hypercholesterolemia
por: Zorzo, R. A., et al.
Publicado: (2023)

Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer
por: Yu, J, et al.
Publicado: (2003)

Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies
por: Trompet, S., et al.
Publicado: (2015)

Benefit of a Second Opinion for Lung Cancer: No Metastasis to the Kidney but a Synchronous Primary Renal Neoplasm
por: ter Avest, Marleen J., et al.
Publicado: (2014)

Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia
por: Boks, M. P., et al.
Publicado: (2018)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2008)

Angular distributions of the analysing power in the excitation of low lying states of 56Co
por: van Zyl, J J, et al.
Publicado: (2012)

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
por: Leung, W K, et al.
Publicado: (2005)

METH-2 silencing and promoter hypermethylation in NSCLC
por: Dunn, J R, et al.
Publicado: (2004)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
por: Shaw, R J, et al.
Publicado: (2009)

Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia
por: Roman-Gomez, J, et al.
Publicado: (2004)

Quantification of [(18)F]afatinib using PET/CT in NSCLC patients: a feasibility study
por: van de Stadt, E. A., et al.
Publicado: (2020)

Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma
por: Gao, S, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_80hbfgvma33hmhohce1mi8lh31